The Mammalian Protein (rbet1) Homologous to Yeast Bet1p Is Primarily Associated with the Pre-Golgi Intermediate Compartment and Is Involved in Vesicular Transport from the Endoplasmic Reticulum to the  Golgi Apparatus by Zhang, Tao et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/97/12/1157/12 $2.00
The Journal of Cell Biology, Volume 139, Number 5, December 1, 1997 1157–1168
http://www.jcb.org 1157
 
The Mammalian Protein (rbet1) Homologous to Yeast Bet1p Is
Primarily Associated with the Pre-Golgi Intermediate Compartment and
Is Involved in Vesicular Transport from the Endoplasmic Reticulum to the 
Golgi Apparatus
 
Tao Zhang, Siew Heng Wong, Bor Luen Tang, Yue Xu, Frank Peter, V. Nathan Subramaniam,
and Wanjin Hong
 
Membrane Biology Laboratory, Institute of Molecular and Cell Biology, Singapore 119076, Singapore
 
Abstract. 
 
Yeast Bet1p participates in vesicular trans-
port from the endoplasmic reticulum to the Golgi appa-
 
ratus and functions as a soluble 
 
N
 
-ethylmaleimide–sen-
sitive factor attachment protein receptor (SNARE) 
associated with ER-derived vesicles. A mammalian 
protein (rbet1) homologous to Bet1p was recently iden-
tified, and it was concluded that rbet1 is associated with 
the Golgi apparatus based on the subcellular localiza-
tion of transiently expressed epitope-tagged rbet1. In 
the present study using rabbit antibodies raised against 
the cytoplasmic domain of rbet1, we found that the ma-
jority of rbet1 is not associated with the Golgi appara-
tus as marked by the Golgi mannosidase II in normal 
rat kidney cells. Rather, rbet1 is predominantly associ-
ated with vesicular spotty structures that concentrate in 
the peri-Golgi region but are also present throughout 
the cytoplasm. These structures colocalize with the 
KDEL receptor and ERGIC-53, which are known to be 
enriched in the intermediate compartment. When the 
Golgi apparatus is fragmented by nocodazole treat-
ment, a significant portion of rbet1 is not colocalized 
with structures marked by Golgi mannosidase II or the 
KDEL receptor. Association of rbet1 in cytoplasmic 
spotty structures is apparently not altered by preincu-
 
bation of cells at 15
 
8
 
C. However, upon warming up 
from 15 to 37
 
8
 
C, rbet1 concentrates into the peri-Golgi 
region. Furthermore, rbet1 colocalizes with vesicular 
stomatitis virus G-protein en route from the ER to the 
Golgi. Antibodies against rbet1 inhibit in vitro trans-
port of G-protein from the ER to the Golgi apparatus 
in a dose-dependent manner. This inhibition can be 
neutralized by preincubation of antibodies with recom-
binant rbet1. EGTA is known to inhibit ER-Golgi 
transport at a stage after vesicle docking but before the 
actual fusion event. Antibodies against rbet1 inhibit 
ER-Golgi transport only when they are added before 
the EGTA-sensitive stage. These results suggest that 
rbet1 may be involved in the docking process of ER-
derived vesicles with the 
 
cis
 
-Golgi membrane.
 
P
 
rotein
 
 transport along the exocytotic and endocy-
totic pathways is primarily mediated via various
types of transport vesicles that bud from one mem-
brane compartment and fuse with a target compartment
(Palade, 1975; Pryer et al., 1992; Rothman, 1994; Hong,
1996; Rothman and Wieland, 1996; Schekman and Orci,
1996). Soluble 
 
N
 
-ethylmaleimide–sensitive factor (NSF)
 
1
 
and its yeast counterpart (Sec18p) have been shown to
participate in many different transport events (Graham
and Emr, 1991; Whiteheart and Kubalek, 1995). Soluble
NSF attachment proteins (SNAPs) or the yeast counter-
part Sec17p is essential for membrane recruitment and
functional activity of NSF (Clary et al., 1990; Griff et al.,
1992; Whiteheart and Kubalek, 1995). These soluble factors
function in conjunction with SNAP receptors (SNAREs)
associated with the vesicles and target membranes. SNAREs
are key determinants of the specificity of vesicle docking
and fusion events (Rothman, 1994; Whiteheart and Kubalek,
1995).
To account for the specificity of vesicle transport, the
SNARE hypothesis predicts that the specific docking and
fusion of vesicles with the target compartment is primarily
mediated by interaction between v-SNAREs on vesicles
with t-SNAREs on the target membrane (Söllner et al.,
1993; Ferro-Novick and Jahn, 1994; Rothman, 1994; Roth-
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man and Warren, 1994; Scheller, 1995; Südhof, 1995; Pfef-
fer, 1996). Yeast Bet1p is an integral membrane protein
anchored to the ER membrane by its COOH-terminal hy-
drophobic membrane anchor. Bet1p is incorporated into
ER-derived transport vesicles and functions as a v-SNARE
for docking and/or fusion of the vesicle with the early Golgi
subcompartment (Newman et al., 1990; Dascher et al.,
1991; Ossig et al., 1991; Rexach et al., 1994; Sögaard et al.,
1994). By searching the expressed sequence tags (EST) da-
tabase with the Bet1p sequence, we have identified human
and mouse homologues of Bet1p. The rat homologue (rbet1)
was recently cloned and reported (Hay et al., 1996). By ex-
amining the subcellular localization of an epitope-tagged
rbet1 transiently expressed in COS cells, it was concluded
that rbet1 is associated with the Golgi apparatus (Hay et al.,
1996, 1997). Since Bet1p is primarily associated with the ER
and ER-derived vesicles (Newman et al., 1990; Dascher et al.,
1991; Ossig et al., 1991; Rexach et al., 1994; Sögaard et al.,
1994), the proposed Golgi localization of rbet1 raised the
possibility that rbet1 may be involved in a transport event
different from that of Bet1p and may therefore not be a
functional counterpart. Furthermore, the functional aspect
of rbet1 has not been investigated. To clarify these impor-
tant issues, we have examined the subcellular localization
of endogenous rbet1 as well as its involvement in ER-
Golgi transport. Our results suggest that rbet1 is preferen-
tially associated with the pre-Golgi intermediate compart-
ment and that rbet1 participates in ER-Golgi transport.
 
Materials and Methods
 
cDNA Cloning and Sequencing
 
EST clones that have open reading frames encoding proteins homologous
to Bet1p were revealed using the BLAST program. (These squence data
can be found under accession numbers R52442, AA305708, AA112610,
AA305267, and W84841 for human, H35645 for rat, and AA245530, W70983,
and W18376 for mouse.) The complete coding sequence of EST clones
R52442 for human (with oligonucleotide 1 and 2), H35645 for rat (with
oligonucleotide 3 and 4), and W70983 for mouse (with oligonucleotide 5
and 6) bet1 were confirmed by sequencing using the following oligonucle-
otides: 1, 5
 
9
 
CGGGATCCATGAGGCGTGCAGGCCTGGGTGAAG-
GAGTAC; 2, 5
 
9
 
GGAAGCTTTCACCTTTGGTTTGGCCTCCCCTC-
TGG; 3, 5
 
9
 
GGGGATCCATGAGCCGTGCAGCCCTGGGTGATGG; 4,
5
 
9
 
GGAAGCTTTCAGGTTTTACCTAGAAATCCAG; 5, 5
 
9
 
ACCCAC-
TATTAGCATAGCCAT; and 6, 5
 
9
 
AATCACAATTTGATTCCACAA.
 
Expression and Purification of Recombinant Proteins
 
For the production of recombinant glutathione-S-transferase (GST) fu-
sion proteins, the cytoplasmic regions of hbet (residues 1–86) and rbet
(residues 1–81) were retrieved by PCR with oligonucleotides 1 and 2
(R52442 as the template), or 3 and 4 (H35645 as the template). The PCR
products were digested with BamHI and EcoRI restriction enzymes and
subcloned into BamHI/EcoRI sites of the bacterial expression vector
pGEX-KG (Guan and Dixon, 1991). The ligated DNA was transformed
into DH5
 
a
 
 cells and ampicillin resistant colonies expressing the GST fu-
sion proteins were screened as described (Sambrook
 
 
 
et al., 1989). Purifica-
tion of GST-hbet1 and GST-rbet1 was performed as described previously
(Lowe et al., 1996).
 
Antibodies
 
For the preparation of polyclonal antibodies against hbet and rbet1, GST-
hbet1 or GST-rbet1 proteins (400 
 
m
 
g) emulsified in complete Freund’s ad-
juvant were injected subcutaneously into two local New Zealand rabbits.
Booster injections containing similar amounts of the antigens emulsified
in incomplete Freund’s adjuvant were performed after 2, 4, 6, 9, and 12 wk.
Rabbits were bled 10 d after the second and subsequent booster injec-
tions. Affinity purification of specific antibodies was performed using the
GST-rbet1 protein coupled to cyanogen bromide–activated Sepharose (3
mg/ml Sepharose bead). Briefly, 3 ml of antiserum was diluted with 3 ml
of PBS and then incubated with the coupled beads for 2 h at room temper-
ature. The beads were washed extensively with PBS, buffer A (50 mM
Tris, pH 7.4, 500 mM NaCl), buffer B (50 mM Tris, pH 7.4, 150 mM NaCl,
1% Triton X-100), and then PBS. Specific antibodies were eluted with 10 ml
of immunopure IgG elution buffer (Pierce Chemical Co., Rockford, IL).
Collected fractions (1 ml each) were analyzed by SDS-PAGE to deter-
mine fractions containing the antibodies. Fractions containing the anti-
bodies were pooled and either dialyzed against PBS or transport buffer
(25 mM Hepes-KOH, pH 7.2, 125 mM KOAc). Rabbit polyclonal anti-
bodies against 
 
a
 
2,6-sialyltransferase and monoclonal antibody HFD9
against GS28 have been described previously (Subramaniam et al., 1995,
1996). Polyclonal antibodies against the intermediate compartment (IC)
marker p58 (Saraste et al., 1987; Saraste and Svensson, 1991) were kindly
provided by J. Saraste (University of Bergen, Norway). Monoclonal anti-
body against ERGIC-53, the human counterpart of p58 (Schweizer et al.,
1988, 1990), was kindly provided by H.-P. Hauri (University of Basel,
Switzerland). Monoclonal antibody against mammalian KDEL receptor
has been described previously (Tang et al., 1995
 
b
 
). Monoclonal antibody
against Golgi mannosidase II was purchased from Babco (Berkeley, CA).
Monoclonal antibody against Rab1 (Plutner et al., 1991) was kindly pro-
vided by W.E. Balch. Rabbit polyclonal antibodies against syntaxin 5 were
described recently (Subramaniam et al., 1997). Polyclonal antibodies
against 
 
a
 
-SNAP and syntaxin 6 were raised in rabbit with corresponding
purified recombinant proteins. Specific antibodies were affinity-purified
as described above for rbet1 antibodies. 
 
Immunofluorescence Microscopy
 
Immunofluorescence microscopy was performed as described previously
(Subramaniam et al., 1995; Lowe et al., 1996; Tang et al., 1997). Briefly,
cells grown on coverslips were washed twice with PBSCM (PBS contain-
ing 1 mM CaCl and 1 mM MgCl
 
2
 
) and then fixed with 3% paraformalde-
hyde in PBSCM for 30 min at 4
 
8
 
C. After sequentially washing with PBSCM,
50 mM NH
 
4
 
Cl in PBSCM, and PBSCM, cells were permeabilized with
PBSCMS (PBSCM containing 0.2% saponin) for 20 min at room tempera-
ture. Incubation with primary antibodies (5–10 
 
m
 
g/ ml) in fluorescence di-
lution buffer (PBSCM with 5% normal goat serum, 5% FBS, and 2%
BSA, pH 7.6) was performed for 1 h at room temperature. After washing
three times with PBSCMS, cells were incubated with rhodamine- or FITC-
conjugated secondary antibodies for 1 h at room temperature. Cells were
then washed five times with PBSCMS, mounted with Vertastain (Vector
Laboratories, Burlingame, CA), and then viewed. Conventional fluores-
cence microscopy was done using a microscope (model Axiophot; Carl
Zeiss, Inc., Thornwood, NY) equipped with epifluorescence optics. Con-
focal microscopy was performed using a scan head (model MRC600; Bio-
Rad Labs, Carlsbad, CA) connected to a microscope (model Axiophot;
Carl Zeiss, Inc.) with epifluorescence optics. 
For temperature treatment of cells, normal rat kidney (NRK) cells
were incubated at 15
 
8
 
C for 3 h and then incubated at 37
 
8
 
C for 0, 5, 10, and
30 min before processing for immunofluorescence microscopy. Infection
of Vero cells with the ts045 strain of vesicular stomatitis virus (VSV) and
the subsequent processing for immunofluorescence microscopy were per-
formed as described previously (Tang et al., 1993, 1995
 
b
 
, 1997). For the
treatment of cells with brefeldin A or nocodazole, cells grown on cover-
slips were incubated in the presence of brefeldin A (10 
 
m
 
g/ml) or nocoda-
zole (10 
 
m
 
g/ml) for 1 h at 37
 
8
 
C, washed twice with PBSCM, and then fixed
in 3% paraformaldehyde. Fixed cells were then permeabilized and incu-
bated with antibodies against rbet1 and monoclonal antibodies against
mannosidase II, the KDEL receptor, or G-protein of VSV for 1 h at room
temperature. After washing three times with PBSCMS, cells were incu-
bated with rhodamine-conjugated goat anti–rabbit IgG (10 
 
m
 
g/ml) and
FITC-conjugated sheep anti–mouse (10 
 
m
 
g/ml) for 1 h at room tempera-
ture. After washing extensively, coverslips were then mounted as de-
scribed above.
 
Immunoprecipitation and Immunoblot Analysis
 
rbet1-specific antibodies (100 
 
m
 
g) bound to protein A–Sepharose beads
(Pharmacia Biotech, Inc., Piscataway, NJ) were incubated overnight with
3 mg of Golgi extracts in incubation buffer (20 mM Hepes, pH 7.2, 100
mM KCl, 1 mM DTT, 10 mM EDTA, 0.2 mM ATP) with 1% Triton X-100 
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at 4
 
8
 
C. Beads were then washed twice in incubation buffer with 0.5% Tri-
ton X-100 and then twice in incubation buffer with 0.2% Triton X-100.
Immunoprecipitates were separated on SDS-PAGE and transferred to a
Hybond-C extra nitrocellulose filter before sequential incubation with pri-
mary antibodies (10 
 
m
 
g/ml) and 
 
125
 
I–protein A (0.1 
 
m
 
Ci/ml), followed by
autoradiography. Incubation of the filter with primary antibodies and
 
125
 
I–protein A and washing of the filter were performed in blocking buffer
(PBS containing 5% skim milk and 0.05% Tween 20), PBS, and PBST (PBS
containing 0.05% Tween 20), respectively.
 
In Vitro ER-Golgi Transport
 
The ER to Golgi transport assay using semiintact cells was performed as
described previously (Beckers et al., 1987; Balch et al., 1994). Briefly,
NRK cells were grown on 10-cm Petri dishes to form a confluent mono-
layer and infected with a temperature-sensitive strain of the vesicular sto-
matitis virus, VSVts045, at 32
 
8
 
C for 3–4 h. The cells were pulse-labeled
with [
 
35
 
S]methionine (100 
 
m
 
Ci/ml) at the restrictive temperature (40
 
8
 
C)
for 10 min and perforated on ice by hypotonic swelling and scraping.
These semiintact cells were then incubated in a complete assay cocktail of
40 
 
m
 
l containing (in final concentrations) 25 mM Hepes-KOH, pH 7.2, 90
mM KOAc, 2.5 mM MgOAc, 5 mM EGTA, 1.8 mM CaCl
 
2
 
, 1 mM ATP, 5
mM creatine phosphate, 0.2 IU of rabbit muscle creatine phosphokinase,
25 
 
m
 
g of cytosol (Davidson and Balch, 1993), and 5 
 
m
 
l (25–30 
 
m
 
g of pro-
tein; 1–2 
 
3
 
10
 
5
 
) of semiintact cells. Additional reagents were added as indi-
cated in Results. For a standard assay, samples were incubated for 90 min
at 32
 
8
 
C, and transport was terminated by transfer to ice. The membranes
were collected by a brief spin, solubilized in 60 
 
m
 
l of 0.2% SDS, 50 mM Na
citrate, pH 5.5. After boiling for 5 min, the samples were digested over-
night at 37
 
8
 
C in the presence of 2.5 U of endoglycosidase H (endo H), and
the reaction was then terminated by adding 5
 
3
 
 concentrated gel sample
buffer. The samples were analyzed by 7.5% SDS–polyacrylamide gels.
The transport was quantified using a PhosphorImager (Molecular Dy-
namics, Sunnyvale, CA). For antibody inhibition of transport assay, rbet1
antibodies were added into the complete assay cocktail and incubated on
ice for 60 min to allow the antibodies to diffuse into semiintact cells. To
neutralize antibody inhibition, different amounts of GST-rbet1 fusion pro-
teins were incubated with rbet1 antibody on ice for 30 min before incuba-
tion with complete assay cocktail. In the case of the two-stage assay, after
Stage I incubation for 60 min at 32
 
8
 
C in a complete assay cocktail supple-
mented with 10 mM EGTA but without Ca
 
2
 
1
 
, membranes were spun for
20 s at full speed in an Eppendorf table top centrifuge and subsequently
resuspended in fresh assay cocktail with Ca
 
2
 
1
 
 by pipetting up and down 10
times with a yellow pipette tip. Additional reagents were added as indi-
cated in the Results. Samples were incubated for 30 min at 32
 
8
 
C, and
transport was terminated by transferring to ice. 
 
In Vitro Binding Assays
 
Golgi membranes (3 mg) were centrifuged at 12,000 
 
g
 
 for 15 min at 4
 
8
 
C,
and the pellet was extracted with 500 
 
m
 
l of incubation buffer (100 mM
KCl, 20 mM Hepes pH 7.3, 2 mM EDTA, 2 mM DTT, 0.2 mM ATP) con-
taining 1% Triton X-100 at 4
 
8
 
C for 1 h with agitation. The extracted mem-
branes were diluted with 500 
 
m
 
l of incubation buffer without Triton X-100
and then centrifuged at 100,000 
 
g
 
 at 4
 
8
 
C for 1 h. Beads containing 2 
 
m
 
g
GST–
 
a
 
-SNAP or GST alone were washed twice with incubation buffer
containing 0.5% TX-100 (1 ml each) and then incubated with different
amounts of the Golgi extract in a total volume of 100 
 
m
 
l at 4
 
8
 
C for 3 h with
agitation. Beads were then washed three times with incubation buffer with
0.5% Triton X-100, once with incubation buffer with 0.1% Triton X-100,
and then processed for immunoblot analysis to detect rbet1.
 
Results
 
Mammalian Homologues of Bet1p Are Well Conserved
 
Searching the EST database with the yeast Bet1p sequence
led to the identification of an EST clone (accession num-
ber R52442) encoding a putative human homologue. Dur-
ing the course of our study, a rat homologue (rbet1) was
published (Hay et al., 1996), and more EST clones for
the human (accession numbers AA305708, AA112610,
AA305267, and W84841) as well as for mouse (accession
numbers AA245530, W70983, and W18376) homologues
were subsequently identified in the database. The human
and mouse EST clones were sequenced to obtain the cod-
ing nucleotide sequence and hence the amino acid se-
quences of human and mouse bet1. As aligned in Fig. 1,
human, rat, and mouse bet1 (hbet1, rbet1, and mbet1, re-
spectively) are highly homologous (hbet1 is 
 
z
 
93% identi-
cal to rbet and mbet1, while rbet1 and mbet1 share over
98% identity). All the mammalian homologues are 
 
z
 
20%
identical to Bet1p and share an overall amino acid se-
quence similarity of about 38–40% with Bet1p. The re-
combinant cytoplasmic domain of hbet1 was initially ex-
pressed as a fusion protein to GST (GST-hbet1) and was
used to immunize rabbits. Polyclonal antibodies against
hbet1, however, cross-react poorly with rbet1 in NRK cells,
despite the fact that hbet1 and rbet1 are highly homolo-
gous. To facilitate our morphological and functional stud-
ies in NRK cells, we subsequently expressed the cytoplas-
mic region (residues 1–81) of rbet1 (GST-rbet1), and
affinity-purified rabbit antibodies against GST-rbet1 were
used in all subsequent experiments.
 
rbet1 Is a 17-kD Protein Preferentially Associated
with Membrane Fractions Enriched in the Golgi and 
Intermediate Compartment
 
When the total membrane fraction derived from NRK
cells was analyzed by immunoblot using rbet1 antibodies,
a major polypeptide of about 17-kD was detected (Fig. 2
 
A
 
, lane 
 
2
 
). Detection of this polypeptide was abolished by
preincubation of antibodies with GST-rbet1 (Fig. 2 
 
A
 
, lane
 
3
 
) but not with GST (data not shown), demonstrating that
the 17-kD polypeptide is rbet1. When rat liver total mem-
branes, microsomal membranes, and Golgi membranes
(GM) were analyzed by immunoblot, rbet1 was enriched
in the GM fraction (Fig. 2 
 
B
 
, 
 
upper panel
 
). Markers of the
IC are also known to be enriched in the GM fraction when
separated by sucrose gradient (Saraste et al., 1987; Schwei-
zer et al., 1988). As shown, similar to 
 
a
 
2,6-sialyltransferase
(Fig. 2 
 
B
 
, 
 
middle panel
 
), the IC marker p58 is also enriched,
although to a lesser extent, in the GM fraction (Fig. 2 
 
B
 
,
 
lower panel
 
).
 
rbet1 Is a SNARE and Interacts with GS28
and Syntaxin 5
 
When increasing amounts of Golgi extract were incubated
with immobilized recombinant 
 
a
 
-SNAP fused to GST
(GST–
 
a
 
-SNAP), increased amounts of rbet1 were found
to be retained by the beads (Fig. 3 
 
A
 
). Under identical
conditions, rbet1 was not retained by immobilized GST or
several other GST fusion proteins (data not shown). Fur-
Figure 1. The mammalian bet1 proteins are highly conserved.
The amino acid sequences of human, rat, and mouse bet1 are
aligned and residues identical among them are shaded. 
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thermore, 
 
a
 
-SNAP was detected in the immunoprecipitate
of rbet1 antibodies but not in the immunoprecipitate of
control antibodies (Fig. 3 
 
B
 
). These results demonstrate
that rbet1 functions as a SNARE.
When the immunoprecipitate of rbet1 antibodies was
analyzed by immunoblot, GS28 and syntaxin 5 were de-
tected (Fig. 4 
 
A
 
). The antibodies against syntaxin 5 detect
specifically two polypeptides of 38 and 32 kD, respectively
(Subramaniam et al., 1997). As shown, the 38-kD form
was preferentially coimmunoprecipitated with rbet1, while
the 32-kD form was barely detectable. GS28 and syntaxin
5 are two 
 
cis
 
-Golgi SNAREs involved in ER-Golgi trans-
port (Banfield et al., 1994; Dascher et al., 1994; Nagahama
et al., 1996; Subramaniam et al., 1996). The coimmunopre-
cipitation of GS28 and syntaxin 5 by rbet1 antibodies is
specific because neither GS28 nor syntaxin 5 was detected
in the immunoprecipitate of control antibodies. Under iden-
tical conditions, syntaxin 6, another Golgi SNARE (Bock
et al., 1996), was not coimmunoprecipitated by rbet1 anti-
bodies (Fig. 4 
 
B
 
). In addition, we have observed that rbet1
could also be coimmunoprecipitated by GS28 and syntaxin
5 antibodies (data not shown). These results suggest that
rbet1 exists in a protein complex that contains GS28 and
syntaxin 5.
 
Predominant Association of rbet1 with the
Intermediate Compartment
 
Using affinity-purified antibodies against rbet1, we have
examined the subcellular localization of endogenous rbet1
in NRK cells by indirect immunofluorescence microscopy.
As shown in Fig. 5, rbet1 is predominantly detected in ve-
sicular structures located throughout the entire cytoplasm
with a higher concentration around the perinuclear region
(Fig. 5, 
 
a
 
 and 
 
d
 
). This labeling was totally abolished when
the antibodies were preincubated with GST-rbet1 (data
not shown). A majority of these vesicular structures is also
labeled by a monoclonal antibody against the mammalian
KDEL receptor (Fig. 5, 
 
b
 
 and 
 
c
 
) (Tang et al., 1995
 
a
 
), which
is known to be enriched in the pre-Golgi IC (Griffiths et al.,
1994; Tang et al., 1995
 
a
 
,
 
b
 
). However, when double-labeled
with Golgi mannosidase II (Moreman and Robbins, 1991)
(Fig. 5 
 
e
 
), the majority of rbet1-containing structures are
devoid of mannosidase II labeling. Even those perinu-
clear/peri-Golgi rbet1-containing structures have a mor-
phology (more spotty) distinct from that of Golgi man-
nosidase II (Fig. 5 
 
f
 
), suggesting that a significant portion
of these peri-Golgi vesicular structures is juxtaposed to
Golgi apparatus but is probably not part of the Golgi ap-
paratus. 
When cells were treated with nocodazole, which is known
to fragment the Golgi apparatus (Rogalski and Singer,
1984; Turner and Tartakoff, 1989), rbet1 (Fig. 6, 
 
a
 
 and 
 
d
 
)
and the mammalian KDEL receptor (Fig. 6 
 
b
 
) remained
predominantly associated with cytoplasmic spotty struc-
tures, while the Golgi apparatus marked by mannosidase
II became fragmented into several patches (Fig. 6 
 
e
 
). Un-
der this condition, it is interesting to note that a significant
portion of the spotty structures marked by rbet1 and the
KDEL receptor is no longer colocalized, suggesting that
Figure 2. rbet1 is a 17-kD protein enriched in the membrane
fraction of the Golgi and the IC. (A) Total membrane fraction of
NRK cells was resolved by SDS-PAGE and transferred to a fil-
ter. The filter was incubated with rbet1 antibodies in the absence
(lane 2) or presence of GST-rbet1 (lane 3). (B) Total membrane
(TM), microsomal membrane (MM), and Golgi membrane (GM)
fractions derived from rat liver were analyzed by immunoblot to
detect rbet1, a2,6-sialyltransferase (ST), and the IC-enriched
protein p58.
Figure 3. rbet1 is a SNARE. (A)
The indicated amounts of Golgi ex-
tract were incubated with 2 mg of
immobilized GST–a-SNAP. After
extensive washing, the beads were
analyzed by immunoblot to detect
rbet1. (B) Golgi extract was immu-
noprecipitated with rbet1 antibod-
ies or control antibodies and the im-
munoprecipitates were analyzed by
immunoblot to detect rbet1 and
a-SNAP.
Figure 4. rbet1 exists in a protein complex that contains GS28
and syntaxin 5. (A) Golgi extract was immunoprecipitated with
rbet1 antibodies or control antibodies. The immunoprecipitates
were analyzed by immunoblot to detect rbet1, GS28, and syn-
taxin 5. (B) The immunoprecipitate of rbet1 and control antibod-
ies, together with 100 mg of Golgi extract, were analyzed by im-
munoblot to detect rbet1 and syntaxin 6.
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rbet1 and KDEL receptor may reside in distinct structures
of the IC. Under this condition, partial colocalization of
rbet1 and KDEL receptor in larger dots could be detected,
and these structures may either represent the IC or the
fragmented Golgi apparatus. Furthermore, it is obvious
that the majority of rbet1-containing structures is negative
for Golgi mannosidase II labeling (Fig. 6 f). Some rbet1-
containing spotty structures are seen in the vicinity of
those marked by mannosidase II, although they are not
well colocalized, suggesting that this fraction of rbet1 may
be associated with a subregion of the fragmented Golgi
apparatus that is not enriched in the Golgi mannosidase II.
When cells were treated with brefeldin A, which is
known to have differential effects on proteins enriched in
the IC as compared with resident Golgi proteins (Klausner
et al., 1992; Tang et al., 1995a), rbet1 is redistributed into
spotty structures (Fig. 7, a and c) that are also marked by
KDEL receptor (Fig. 7 b). Under the same condition, Golgi
mannosidase II is redistributed into the ER-like structures
(Fig. 7 d). Redistribution by brefeldin A into spotty struc-
tures is a characteristic of proteins associated with the IC,
including ERGIC-53/p58 and KDEL receptor (Saraste and
Svensson, 1991; Tang et al., 1993, 1995a). These results,
taken together, suggest that rbet1 is preferentially associ-
ated with the IC, although a fraction is also associated with
a subregion (most likely the cis-face) of the Golgi appara-
tus under steady state and that the majority of rbet1 can be
shifted to the IC under some conditions, such as treatment
with brefeldin A.
To provide additional evidence for the preferential asso-
ciation of rbet1 with the IC, we have double-labeled cells
with antibodies against rbet1 and a monoclonal antibody
against ERGIC-53, which is normally enriched in the IC
and cycles preferentially between the IC and the ER (Schwei-
zer et al. 1988, 1990). Because only polyclonal antibodies
against rbet1 and monoclonal antibody specific for human
ERGIC-53/p58 are available, this experiment was only
performed in a human cell line (HeLa). As shown in Fig.
8, at steady state rbet1 and ERGIC-53 are colocalized well
in spotty structures enriched in the Golgi region (Fig. 8, A
and B). In cells pretreated with brefeldin A, they are simi-
larly colocalized in the spotty structures enriched in the
perinuclear region (Fig. 8, C and D). When cells were pre-
incubated at 158C, rbet1 and ERGIC-53 could be seen to
concentrate in a compact Golgi-like structure, although
rbet1 could be also seen in peripheral spotty structures
while association of ERGIC-53 with the ER became more
obvious. ERGIC-53 has also been shown previously to
shift to a compact Golgi-like structure when cells are pre-
incubated at 158C (Lippincott-Schwartz et al., 1990). The
effect of 158C preincubation on the IC markers in HeLa
cells is different from that observed in NRK cells, in which
the IC markers became more enriched in peripheral spotty
structures as shown above. These results further support
our interpretation that rbet1 is preferentially associated
with the IC.
Dynamic Distribution of rbet1 between the Peripheral 
and peri-Golgi IC
Proteins in the IC are dynamically distributed between the
peripheral structures and the perinuclear structures around
the Golgi apparatus (peri-Golgi), and cargo proteins in the
ER are transported to the Golgi apparatus via migration/
maturation of peripheral IC to the peri-Golgi region or di-
rectly from the peri-Golgi IC (Saraste and Svensson, 1991;
Figure 5. Double-labeling of
rbet1 (a and d) with the KDEL
receptor (KDEL-R) (b) or
Golgi mannosidase II (man
II) (e) in NRK cells. The
merged pictures (c and f) are
also presented. Bar, 10 mm.The Journal of Cell Biology, Volume 139, 1997 1162
Lotti et al., 1992; Plutner et al., 1992; Lippincott-Schwartz,
1993; Tang et al., 1993, 1995a; Balch et al., 1994; Tisdale et al.,
1997). Incubation of cells at 158C is known to block trans-
port from the ER to the Golgi at the level of the IC and
also causes an increase in the concentration of IC proteins
in the peripheral structures (Saraste and Svensson, 1991;
Lippincott-Schwartz, 1993; Tang et al., 1993, 1995a). When
cells were preincubated at 158C, rbet1 and the KDEL re-
ceptor were colocalized in the same vesicular structures
spreading in the entire cytoplasm (Fig. 9, a and b). When
158C-arrested cells were warmed up to 378C for 5–10 min,
rbet1 and the KDEL receptor were seen to shift to the
peri-Golgi region (Fig. 9, c–f). At later time points, rbet1
and the KDEL receptor reach a steady-state distribution
(Fig. 9, g and h). These results suggest that, like other IC
proteins, rbet1 is dynamically distributed between the pe-
ripheral and peri-Golgi IC. This interpretation is also con-
sistent with our observation that, like other IC proteins,
the fractions of rbet1 associated with the peripheral and
peri-Golgi IC vary among different cell types (data not
shown).
The IC is a dynamic collection of specialized ER regions
involved in COPII vesicle budding, budded vesicles, and
vesicular-tubular intermediates involved in cargo transport
from the ER to the Golgi apparatus (Bonatti et al., 1989;
Schweizer et al., 1990; Tang et al., 1993; Krijnse-Locker et al.,
1994). To gain more insight into the functional significance
of rbet1 association with the IC, we infected Vero cells
with the ts045 strain of VSV, the G-protein of which is mu-
tated in such a way that it can not be exported from the
ER at the restricted temperature (408C). The infected cells
were maintained at 408C to restrict G-protein to the ER.
Cells were then processed for double-labeling for rbet1
and G-protein. As shown in Fig 10 A, b, G-protein is
mainly distributed in the ER with a significant amount
colocalized with vesicular structures marked by rbet1 (Fig.
10 A, a and c), suggesting that G-protein could distribute
into the structures marked by rbet1. The G-protein associ-
ated with these vesicular structures is most likely enriched
in the ER region involved in COPII vesicle budding, which
was defined as part of the ER export complex (equivalent
to the IC) (Bannykh et al., 1996; Bannykh and Balch,
1997). Under this condition, some rbet1 could be detected
in the reticular structures of the ER, particularly at the pe-
ripheral area of the cell (Fig. 10 A, a). This observation is
consistent with the fact that IC proteins can be detected in
the ER under certain conditions and/or in some cell types
(Saraste and Svensson, 1991; Tang et al., 1995b). ER label-
ing for rbet1 is not so obvious in uninfected Vero cells
maintained at 378C (Fig 10 B, Vero), suggesting that viral
infection, extensive accumulation of cargo molecule in the
ER, and/or incubation of cells at 408C caused a shift of a
fraction of rbet1 from the IC to the ER. Other IC markers,
such as the KDEL receptor and ERGIC-53/p58, are also
Figure 6. NRK cells were treated
with 10 mg/ml nocodazole for 1 h,
fixed, and double-labeled for rbet1
(a and d) with KDEL-R (b) or man
II (e). Also shown are the merged
images (c and f). Bar, 10 mm.Zhang et al. Association of rbet1 with the Intermediate Compartment 1163
seen to be enhanced in the ER when cells were infected
with VSV (Tang et al., 1995a,b). When VSV-infected cells
were shifted from 408C to a permissive temperature (328C)
for 4 min, G-protein was seen to export from the ER and
accumulate in larger peri-Golgi spotty structures (Fig. 10
A, e). Under this condition, a major portion of rbet1 be-
came concentrated in these structures as well (Fig. 10 A, d
and f). Upon incubation at 328C for 12 min, G-protein is
seen in typical Golgi structure (Fig. 10 A, h) while rbet1
revents to small spotty structures (Fig. 10 A, g), and a ma-
jority of these structures are no longer colocalized with
G-protein (Fig. 10 A, i). The dynamic distribution of rbet1
from the peripheral to the peri-Golgi IC correlates well
with transport of cargo proteins from the ER to the Golgi
via peripheral and peri-Golgi IC.
Antibodies against rbet1 Inhibit ER-Golgi Transport
The predominant association of rbet1 with the IC and the
observation that rbet1 colocalizes with a cargo protein en
route to the Golgi suggest that rbet1 may be involved in
protein transport from the ER to the Golgi apparatus in
mammalian cells. To establish this point, we have exam-
ined whether protein transport from the ER to the Golgi
could be inhibited by antibodies against rbet1. We adopted
the well-established in vitro ER-Golgi transport system us-
ing VSV ts045–infected NRK cells (Beckers et al., 1987;
Balch et al., 1994). Infected NRK cells were pulse-labeled
with [35S]methionine at 408C so that the labeled G-protein
is restricted to the ER. The plasma membrane was then se-
lectively perforated, and the cells were depleted of endog-
enous cytosol. G-protein can be transported from the ER
to the Golgi when these semiintact cells are incubated at
permissive temperature (328C) supplemented with exoge-
nous cytosol and an ATP-regenerating system. ER-Golgi
transport was measured by following the extent of conver-
sion of ER-restricted endo H–sensitive G-protein into
endo H–resistant Golgi form. As shown in Fig. 11 A, no
transport was detected when semiintact cells were incu-
bated on ice (Fig. 11 A, lane 1). The majority of G-protein
is converted into endo H–resistant Golgi form when incu-
bated at 328C (lane 2). Transport from the ER to the Golgi
was however inhibited by antibodies against rbet1 in a
dose-dependent manner (lanes 3–7). Inhibition was not so
obvious when only 0.3 mg of antibodies was added (lane
3). However, z60% of the G-protein was not converted
into the Golgi form when 0.6 mg of antibodies was added
(lane 4). Transport was almost completely inhibited when
0.9 mg (lane 5) or more (lanes 6–7) of antibodies were
added. The inhibition is specific because the same amount
of heat-denatured antibodies had no effect on transport
(compare Fig. 11 A, lane 4, with Fig 11 B, lane 3) and com-
parable amounts of antibodies against the KDEL receptor
(Tang et al. 1997), and several other control antibodies
Figure 7. NRK cells were treated with 10 mg/ml brefeldin A for 1 h,
fixed, and double-labeled for rbet1 (a and c) with KDEL-R (b) or
man II (d). Bar, 10 mm.
Figure 8. Double-labeling of rbet1 with ERGIC-53 in control
cells (A and B), cells pretreated with 10 mg/ml brefeldin A for 1 h
(C and D), and cells preincubated at 158C for 3 h (E and F). Bar,
10 mm.The Journal of Cell Biology, Volume 139, 1997 1164
had no effect on ER-Golgi transport of G-protein (data
not shown, also see Subramaniam et al., 1996). Further-
more, inhibition exhibited by antibodies against rbet1
could be neutralized by GST-rbet1 (Fig 11 C). G-protein
transport to the Golgi is almost completely inhibited by 0.8
mg of rbet1 antibodies (lane 4). However, preincubation of
rbet1 antibodies with 0.6 (lane 5) and 1.2 mg (lane 6) of GST-
rbet1 resulted in z60 and 80% of G-protein being con-
verted into the Golgi form. These results, taken together,
suggest that inhibition of ER-Golgi transport by rbet1 an-
tibodies occurs by specific association with endogenous
rbet1. rbet1 is therefore essential for ER-Golgi transport.
rbet1 Antibodies Must Be Present before the
EGTA-sensitive Stage to Achieve Inhibition
In vitro ER-Golgi transport could be inhibited by EGTA
at a stage between vesicle docking and fusion (Rexach and
Schekman, 1991; Balch et al., 1994; Pind et al., 1994; Ari-
dor et al., 1995; Lupashin et al., 1996; Subramaniam et al.,
1996). To gain additional understanding about the involve-
ment of rbet1 in ER-Golgi transport, we have found that
rbet1 antibodies must be present before the EGTA-sensi-
tive stage to exhibit an inhibitory effect (Fig. 12). In this
experiment, in vitro ER-Golgi transport was first per-
formed in the presence of EGTA to arrest transport at the
EGTA-sensitive stage. Semiintact cells were then washed,
resuspended in complete transport cocktail, and resumed
with a second stage of incubation to continue the events
between the EGTA-sensitive stage to the actual mem-
brane fusion. As shown, G-protein remained in the endo
H–sensitive ER form after the first stage of incubation (Fig.
12, lane 10). A second incubation in fresh cytosol and com-
plete transport cocktail allowed almost complete conver-
sion of the EGTA-arrested ER form into the endo H–resis-
tant Golgi form (lane 11). Inclusion of rbet1 antibodies in
standard transport assay inhibited the transport to the
background level (lane 4). However, when rbet1 antibod-
ies were included only in the second stage of incubation,
almost complete transport was achieved, suggesting that
rbet1 antibodies could not inhibit the transport when in-
cluded only in the second stage of transport assay. As shown
previously (Nuoffer et al., 1994; Aridor et al., 1995), GTP-
g-S (lanes 6–7) and a Rab1 monoclonal antibody (Plutner
Figure 9. NRK cells were incubated at 158C for 3 h and then in-
cubated at 378C for the indicated time. The cells were fixed and
double-labeled for rbet1 (a, c, e, and g) with KDEL-R (b, d, f, and
h). Bar, 10 mm.
Figure 10. (A) Vero cells were infected with VSV ts045 and incu-
bated at 408C for 4 h. Cells were then shifted to 328C for the indi-
cated time and fixed. Double-labeling of rbet1 (a, d, and g) with
the envelope protein of VSV (VSVG) (b, e, and h) was per-
formed. The merged images (c, f, and i) are also shown. (B) Con-
trol Vero and NRK cells were fixed and labeled with rbet1 anti-
bodies. Bars, 10 mm.Zhang et al. Association of rbet1 with the Intermediate Compartment 1165
et al., 1991) (lanes 8–9) were also no longer inhibitory to
ER-Golgi transport when supplemented only at the sec-
ond stage of incubation. These results suggest that rbet1
antibodies can no longer gain access to rbet1 or that rbet1
is no longer required after the EGTA-sensitive stage.
Discussion
A Role of rbet1 in ER-Golgi Transport
The identification of mammalian proteins that are structur-
ally related to yeast Bet1p raised the issue as to whether
these proteins represent true functional counterparts of
Bet1p or are members of a similar protein family that par-
ticipate in different transport events. Since Bet1p partici-
pates in vesicular transport from the ER to the Golgi by
functioning as a v-SNARE of ER-derived vesicles (New-
man et al., 1990; Dascher et al., 1991; Ossig et al., 1991;
Rexach et al., 1994; Sögaard et al., 1994), the mammalian
proteins in question should play a similar role if they are
indeed Bet1p counterparts. However, the functional as-
pects of rbet1 have not been investigated by previous stud-
ies (Hay et al., 1996, 1997). In addition to its association
with ER-derived vesicles, the majority of Bet1p is present
in the ER. However, an examination of the subcellular lo-
calization of a transiently expressed epitope-tagged form of
rbet1 has led to the conclusion that rbet1 is primarily as-
sociated with the Golgi apparatus (Hay et al., 1996). The
apparent Golgi association of rbet1 is inconsistent with the
notion that rbet1 is a mammalian counterpart of Bet1p,
but it may rather be participating in a transport event me-
diated by Golgi-derived vesicles. To resolve this discrep-
ancy, we have investigated in detail the subcellular localiza-
tion of endogenous rbet1. It is clear that rbet1 is primarily
associated with the pre-Golgi IC. Since the pre-Golgi IC is
a collection of specialized ER regions involved in vesicle
budding, budded vesicles, and other vesicular-tubular in-
termediates mediating ER-Golgi transport (Hong and Tang,
1993; Bannykh et al., 1996), localization of rbet1 in the IC
is more consistent with its potential role in ER-Golgi trans-
port. To examine the function of rbet1 in mammalian cells,
we showed that antibodies against rbet1 could specifically
inhibit in vitro ER-Golgi transport of VSV G-protein. Fur-
thermore, we demonstrated that rbet1 antibodies must be
present before the EGTA-sensitive stage to achieve an in-
hibition. Since EGTA inhibits ER-Golgi transport at a
stage between vesicle docking and the actual membrane
fusion event (Rexach and Schekman, 1991; Balch et al.,
1994; Pind et al., 1994; Aridor et al., 1995; Lupashin et al.,
1996; Subramaniam et al., 1996), our results suggest that
once ER-derived vesicles have docked onto the cis-Golgi
membrane, rbet1 antibodies are no longer inhibitory in the
transport assay. This observation can be explained in two
alternative ways. One possibility is that rbet1 is only im-
portant for the vesicle docking process but not for the fu-
sion event. Alternatively, once vesicles have docked onto
the cis-Golgi membrane, rbet1 becomes incorporated into
a large SNARE complex in such a way that rbet1 is no
longer accessible to the antibodies. Whatever the underly-
ing mechanism is, our results clearly suggest that rbet1 an-
tibodies must be added before ER-derived vesicles have
undergone the docking process to inhibit ER-Golgi trans-
port. Our results are thus consistent with the notion that
rbet1 is a true mammalian counterpart of Bet1p by func-
Figure 11. rbet1 antibodies specifically inhibit in vitro ER-Golgi
transport. (A) In vitro ER-Golgi transport was performed either
on ice (lane 1) or at 328C (lanes 2–7) supplemented with the indi-
cated amounts of rbet1 antibodies. (B) In vitro ER-Golgi trans-
port was performed either on ice (lane 1) or at 328C (lanes 2–4)
supplemented with 1.2 mg of rbet1 antibodies (lane 3) or the heat-
inactivated antibodies (lane 4). (C) In vitro ER-Golgi transport
was performed either on ice (lane 1) or at 328C (lanes 2–6) in the
absence (lane 3) or in the presence of rat liver cytosol (rlc) (lanes
1 and 2, and 4–6) supplemented with 0.8 mg of rbet1 antibodies
and indicated amounts of GST-rbet1.
Figure 12. rbet1 antibodies must be present before the EGTA-
sensitive stage to exhibit the inhibitory effect on in vitro ER-
Golgi transport. In vitro ER-Golgi transport was performed ei-
ther on ice (lane 1) or at 328C (lanes 2–11) in the absence (lane 3)
or presence of rat liver cytosol (rlc) (lanes 1 and 2, and 4–11). The
standard transport was performed for lanes 1–4. For lanes 5–11,
transport assay was first performed in the presence of 10 mM
EGTA to arrest the transport at the EGTA-sensitive stage fol-
lowed by a washing step and second incubation at 328C to con-
tinue the transport. Reagents were supplemented as indicated.The Journal of Cell Biology, Volume 139, 1997 1166
tioning as a v-SNARE of ER-derived vesicles and that it
participates primarily in the docking process. Our demon-
stration that rbet1 is a SNARE and exists in a GS28- and
syntaxin 5-containing protein complex further supports this
conclusion because both GS28 and syntaxin 5 are involved
in ER-Golgi transport and syntaxin 5 is a t-SNARE of the
cis-Golgi membrane (Hardwick et al., 1992; Banfield et al.,
1994; Dascher et al., 1994; Subramaniam et al., 1996). In an
independent study, it was found that syntaxin 5 but not
GS28 could be coimmunoprecipitated by rbet1 antibodies
(Hay et al., 1997). This study is in contrast to our results
that GS28 could be coimmunoprecipitated by rbet1 anti-
bodies. What could potentially account for this discrep-
ancy remains to be established. One possibility could be
the fact that different rbet1 antibodies were used.
The Role of the IC in ER-Golgi Transport
The IC was originally identified by the accumulation of vi-
ral envelope proteins in morphologically distinct structures
throughout the entire cytoplasm and concentrated in the
peri-Golgi region, when viral-infected cells are incubated
at 158C (Saraste and Kuismanen, 1984; Bonatti et al., 1989;
Schweizer et al., 1990; Tang et al., 1993). More and more
evidence has accumulated supporting the idea that the IC
represents true intermediates in ER-Golgi transport. We
proposed several years ago that the IC represents special-
ized regions of ER devoted to vesicle budding and is
equivalent to the transitional elements seen in pancreatic
acinar cells (Hong and Tang, 1993). We referred to these
specialized ER regions as ER exist sites (ERES). It be-
comes more clear now that the IC is a dynamic collection
of the ERES (equivalent to the transitional elements), ves-
icles derived from ER, and tubular-vesicular intermediates
that are involved in anterograde transport to the Golgi ap-
paratus and retrograde recycling of proteins back to the
ER (Aridor et al., 1995; Tang et al., 1995b; Bannykh et al.,
1996). In a recent study, the IC was also referred to as the
ER export complex, and a three-tier structure was pro-
posed (Bannykh et al., 1996; Bannykh and Balch, 1997).
The first tier consists of closely adjacent buds on a single
ER cisternae, and these buds contain COPII coats. A col-
lection of tier I budding sites encompassing a central cavity
containing a collection of vesicular tubular clusters (VTC)
was defined as tier II. The VTC has COPI coats and can
mediate COPI vesicle budding for recycling back to the
ER. The entire export complex consisting of a local con-
centration of ER budding sites and the central VTC was
defined as tier III. The ER budding profile defined by tier
I and II may be equivalent to the ERES and the ER transi-
tional elements, while the VTC represents the first post-
ER and pre-Golgi membrane structure involved in ER-
Golgi transport. The VTC exists both in peripheral sites as
well as in the Golgi region. The peripheral VTC can be
mobilized to the Golgi region. Furthermore, our knowledge
of the role of the IC/the ER export complex in ER-Golgi
transport has progressed beyond mere morphological de-
scription to recent demonstration that proteins involved in
ER-Golgi transport are concentrated in the IC. These in-
clude components of COPII that mediate vesicle budding
from the ER (Orci et al., 1991; Schaywitz et al., 1995; Pac-
caud et al., 1996; Tang et al., 1997), components of COPI
that are involved in coupling ER-derived vesicles to both
anterograde transport to the Golgi and recycling of pro-
teins back to the ER (Oprins et al., 1993; Aridor et al.,
1995; Griffiths et al., 1995; Lippincott-Schwartz et al., 1995),
and small GTPase Rab1 and 2 that regulate vesicle dock-
ing and/or fusion events in ER-Golgi transport (Plutner et
al., 1991; Nuoffer et al., 1994). The human protein ER-
GIC-53 and its rat counterpart p58 were one of the first
few cellular proteins known to be enriched in the IC and
which cycle preferentially between the IC and the ER
(Schweizer et al., 1990; Saraste and Svensson, 1991). The
recent demonstration that ERGIC-53/p58 is a major com-
ponent of ER-derived COPII vesicles (Rowe et al., 1996)
and is involved in ER-Golgi transport (Tisdale et al., 1997)
further supports the notion that proteins participating in
ER-Golgi transport are enriched in the IC. In our present
study, we have shown that rbet1 is preferentially associ-
ated with the IC. Association of rbet1 with the IC suggests
that it is present in the ERES (tier I and II structures) and/
or the VTC involved in ER-Golgi transport. This interpre-
tation is further supported by our demonstration that
rbet1 is essential for ER-Golgi transport and that its func-
tion in ER-Golgi transport cannot be inhibited by antibod-
ies once vesicles have gone beyond the docking stage. Our
demonstration that rbet1 is a SNARE and exists, together
with GS28 and syntaxin 5, in a protein complex further
confirms this conclusion. 
Currently, how the VTC is mechanistically involved in
ER-Golgi transport remains debatable. Two models have
been recently proposed (Bannykh and Balch, 1997). In the
first, the VTC is a stable independent compartment lo-
cated between ER and the cis-Golgi. The COPII coat me-
diates vesicle formation in the ERES (the transitional ele-
ments or the tier I and II structures of the export complex)
and the derived vesicles fuse with the VTC. Two types of
vesicles are generated from the VTC: one type is gener-
ated by the COPI coat and it is involved in retrograde
transport back to the ER; the formation of the other type
is mediated by an unknown coat, and this type of vesicle is
involved in anterograde transport from the VTC to the cis-
Golgi. In this model, two consecutive vesicle-mediated
transport steps are required for ER-Golgi transport. The
second model suggests that the VTC is derived de novo
from the homotypic fusion of ER-derived COPII vesicles
and undergoes maturation processes to form the cis-most
Golgi compartment, during which COPI-mediated vesicles
would direct recycling of components back to the ER. In
this alternative model, one vesicle budding step and one
homotypic fusion of ER-derived vesicles coupled to COPI-
mediated recycling is sufficient for ER-Golgi transport.
Our studies on rbet1 reported here allow us to propose yet
another model. The ER-derived COPII vesicles could un-
dergo homotypic fusion to form the VTC. The ER-derived
vesicles could also fuse (in a homotypic manner) with pre-
existing VTC. The maturation of the VTC is mediated by
COPI coat to recycle components back to the ER. The
mature VTC then undergoes heterotypic fusion with the
cis-Golgi. Our hypothesis is based on the second model
but also suggests that a heterotypic fusion of the VTC with
the preexisting cis-Golgi is also involved in ER-Golgi trans-
port. According to our model, rbet1 is incorporated into
COPII vesicles and exists as a v-SNARE of the VTC. InZhang et al. Association of rbet1 with the Intermediate Compartment 1167
this way, rbet1 could be involved in heterotypic fusion of
VTC with the cis-Golgi by interacting with syntaxin 5 and
GS28. rbet1 may also participate in the homotypic fusion
during the formation of the VTC. This possibility is consis-
tent with our current knowledge of ER-Golgi transport in
the yeast in which one COPII-mediated vesicle budding
from the ER coupled to a heterotypic fusion is involved in
ER-Golgi transport (Schekman and Orci, 1996). Whether
a structure equivalent to the VTC exists and COPI-medi-
ated recycling participates in the maturation of this equiv-
alent structure during ER-Golgi transport in yeast remains
to be examined. Alternatively, our results are also consis-
tent with the first model in which two vesicle steps are in-
volved in ER-Golgi transport and the VTC is a distinct
stable compartment. In this consideration, rbet1 could
function as a v-SNARE for ER-derived COPII vesicles,
and it is involved in heterotypic fusion with the VTC.
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